These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Prevention of tardive dyskinesia caused by neuroleptic therapy]. Perényi A. Orv Hetil; 1981 Jul 05; 122(27):1627-30. PubMed ID: 6117046 [No Abstract] [Full Text] [Related]
23. Neuroleptic-induced tardive dyskinesia and parkinsonism: changes during several years of continuing treatment. Casey DE, Povlsen UJ, Meidahl B, Gerlach J. Psychopharmacol Bull; 1986 Jul 05; 22(1):250-3. PubMed ID: 2873612 [No Abstract] [Full Text] [Related]
28. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence. Kane JM. J Clin Psychiatry; 2004 Jul 05; 65 Suppl 9():16-20. PubMed ID: 15189107 [Abstract] [Full Text] [Related]
29. Treatment of neuroleptic-induced tardive dyskinesia with levetiracetam: a case series. Bona JR. J Clin Psychopharmacol; 2006 Apr 05; 26(2):215-6. PubMed ID: 16633158 [No Abstract] [Full Text] [Related]
33. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study. Miyaoka T, Furuya M, Yasuda H, Hayashida M, Nishida A, Inagaki T, Horiguchi J. Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):761-4. PubMed ID: 18201810 [Abstract] [Full Text] [Related]
34. [Current data on neurologic sequelae caused by neuroleptics]. Krebs MO. Encephale; 1995 Jun 01; 21 Spec No 3():49-52. PubMed ID: 7628342 [Abstract] [Full Text] [Related]